In accordance with Danish legislation, Novozymes has a two-tier management system comprising the Board of
Directors and the Executive Leadership team, with no individual being a member of both.
Novozymes’ articles of association require the Board of Directors to have four to eight members elected at the annual
shareholders’ meeting, of which there are currently seven. They are elected for one year at a time and cannot be
elected or re-elected after reaching the age of 70. Nominations are based on an evaluation of factors such as
competencies, diversity, independence and prior performance. The Board of Directors also includes three members
elected by employees, who serve four-year terms.
| Board member |
Nationality |
Board tenure |
Election period |
| Jørgen Buhl Rasmussen 1,2,3,6,8 |
Danish |
2011 |
1 year |
| Cees de Jong 1,2,4,6,8 |
Dutch |
2020 |
1 year |
| Heine Dalsgaard 1,6 |
Danish |
2020 |
1 year |
| Sharon James 1,2,7 |
British |
2020 |
1 year |
| Kasim Kutay 1,8 |
British |
2017 |
1 year |
| Kim Stratton 1,2,7,8 |
Australian |
2017 |
1 year |
| Mathias Uhlén 1,7 |
Swedish |
2007 |
1 year |
| Lena Bech Holskov 5 |
Danish |
2013 |
4 years |
| Anders Hentze Knudsen 5 |
Danish |
2013 |
4 years |
| Lars Bo Køppler 5 |
Danish |
2013 |
4 years |
| 1 Elected at the shareholders' meeting |
| 2 Independent |
| 3 Chair of the Board of Directors |
| 4 Vice Chair of the Board of Directors |
| 5 Employee representative |
| 6 Member of the Audit Committee |
| 7 Member of the Innovation Committee |
| 8 Member of the Nomination and Remuneration Committee |
The Board of Directors is accountable to the company’s shareholders for the way the company conducts its business.
The composition of the Board of Directors must therefore be such that the combined competencies of the Board enable
it to inspire, guide and oversee the company’s development, and diligently address and resolve the issues and
challenges faced by the company at any time.
The required competencies are defined in a competency profile that specifies various personal characteristics, skills
and experience. The individual competencies of the members of the Board of Directors are
shown in the presentation of the Board of Directors and Executive Leadership Team.
The Board’s main responsibilities are to:
- Ensure the right management and organizational structure
- Supervise financial, social and environmental performance and the Executive Leadership Team’s day-to-day running
of the company
- Decide the overall management and strategic development of the company
A Chairmanship has been established in accordance with the Articles of Association and the Rules of Procedure for the
Board of Directors. It has two members – the Chair and the Vice Chair – and is responsible for assisting the Board
of Directors in overseeing the Executive Leadership Team’s day-to-day running of the company and reporting back to
the Board of Directors. The Chairmanship is also responsible for planning and preparing meetings of the Board of
Directors.
In addition, the Board of Directors has an Audit Committee that
assists the Board of Directors in monitoring aspects relating to accounting, auditing, internal control and financial reporting. As part of the internal control system, all identified fraud cases and concerns raised are investigated and reported
to the Audit Committee.
Novozymes’ Board of Directors has a Nomination and Remuneration Committee. The Nomination and Remuneration
Committee assists the Board of Directors with nomination of candidates for the Board of Directors, board committees,
and the Executive Leadership Team as well as remuneration of the same.